Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Collet

Showing results (191-200 of 408) with videos related to

Pageof 41
Sort By:
European Heart Journal|April 22, 2014
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryMiguel Sousa-Uva, Robert Storey, Kurt Huber, et al.
Journal of the American College of Cardiology|January 23, 2004
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) studyMiles Dalby, Gilles Montalescot, Claire Bal dit Sollier, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2021
Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysisThomas Mouyen, Thibaut Manigold, Jean-Philippe Collet, et al.
European Heart Journal|September 27, 2013
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary interventionDániel Aradi, Robert F Storey, András Komócsi, et al.
BMJ (Clinical Research Ed.)|February 7, 2012
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisJohanne Silvain, Farzin Beygui, Olivier Barthélémy, et al.
Heart (British Cardiac Society)|July 28, 2011
Non-cardiac surgery in patients with coronary stents: the RECO studyPierre Albaladejo, Emmanuel Marret, Charles-Marc Samama, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 20, 2009
Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery diseaseFarzin Beygui, Shaida Varnous, Gilles Montalescot, et al.
Archives of Cardiovascular Diseases|April 22, 2026
Patients implanted with a leadless pacemaker after transcatheter aortic valve implantation: Results from the MITAVI prospective studyNicolas Lellouche, Eloi Marijon, Vincent Algalarrondo, et al.
American Heart Journal|September 21, 2015
Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trialCyril Pellaton, Guillaume Cayla, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|July 18, 2015
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary interventionGoran Loncar, Olivier Barthelemy, Emmanuel Berman, et al.
Pageof 41

Showing results (191-200 of 408) with videos related to

Sort By:
Pageof 41
European Heart Journal|April 22, 2014
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgeryMiguel Sousa-Uva, Robert Storey, Kurt Huber, et al.
Journal of the American College of Cardiology|January 23, 2004
Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) studyMiles Dalby, Gilles Montalescot, Claire Bal dit Sollier, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 22, 2021
Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysisThomas Mouyen, Thibaut Manigold, Jean-Philippe Collet, et al.
European Heart Journal|September 27, 2013
Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary interventionDániel Aradi, Robert F Storey, András Komócsi, et al.
BMJ (Clinical Research Ed.)|February 7, 2012
Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysisJohanne Silvain, Farzin Beygui, Olivier Barthélémy, et al.
Heart (British Cardiac Society)|July 28, 2011
Non-cardiac surgery in patients with coronary stents: the RECO studyPierre Albaladejo, Emmanuel Marret, Charles-Marc Samama, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 20, 2009
Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery diseaseFarzin Beygui, Shaida Varnous, Gilles Montalescot, et al.
Archives of Cardiovascular Diseases|April 22, 2026
Patients implanted with a leadless pacemaker after transcatheter aortic valve implantation: Results from the MITAVI prospective studyNicolas Lellouche, Eloi Marijon, Vincent Algalarrondo, et al.
American Heart Journal|September 21, 2015
Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trialCyril Pellaton, Guillaume Cayla, Johanne Silvain, et al.
Archives of Cardiovascular Diseases|July 18, 2015
Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary interventionGoran Loncar, Olivier Barthelemy, Emmanuel Berman, et al.
Pageof 41